Tetraphase (TTPH) Prices 10.7M IPO at $7/Share

March 20, 2013 9:47 AM EDT
Get Alerts TTPH Hot Sheet
Trade TTPH Now!
Join SI Premium – FREE
Tetraphase Pharmaceuticals, Inc. (Nasdaq: TTPH) today announced the pricing of its initial public offering of 10,714,286 shares of common stock at a price to the public of $7.00 per share, less underwriting discounts and commissions. Tetraphase’s common stock is expected to begin trading on the NASDAQ Global Market under the symbol “TTPH” on March 20, 2013.

Tetraphase has granted the underwriters a 30-day option to purchase up to 1,607,143 additional shares of common stock at the same price to cover over allotments, if any.

Barclays and BMO Capital Markets are acting as joint book-running managers. Stifel, JMP Securities and Needham & Company are acting as co-managers for the offering.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

IPOs, Trading Halts

Related Entities

Needham & Company, BMO Capital, JMP Securities, Barclays

Add Your Comment